Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
Standard
Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models. / Lambert, Martin; Schimmelmann, Benno G; Schacht, Alexander; Suarez, David; Haro, Josep Maria; Novick, Diego; Wagner, Thomas; Wehmeier, Peter M; Huber, Christian; Hundemer, Hans-Peter; Dittmann, Ralf W; Naber, Dieter.
In: J CLIN PSYCHOPHARM, Vol. 31, No. 2, 2, 2011, p. 226-230.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
AU - Lambert, Martin
AU - Schimmelmann, Benno G
AU - Schacht, Alexander
AU - Suarez, David
AU - Haro, Josep Maria
AU - Novick, Diego
AU - Wagner, Thomas
AU - Wehmeier, Peter M
AU - Huber, Christian
AU - Hundemer, Hans-Peter
AU - Dittmann, Ralf W
AU - Naber, Dieter
PY - 2011
Y1 - 2011
N2 - This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia.
AB - This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Prospective Studies
KW - Follow-Up Studies
KW - Models, Biological
KW - Antipsychotic Agents/therapeutic use
KW - Schizophrenic Psychology
KW - Patient Satisfaction
KW - Schizophrenia/drug therapy
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Prospective Studies
KW - Follow-Up Studies
KW - Models, Biological
KW - Antipsychotic Agents/therapeutic use
KW - Schizophrenic Psychology
KW - Patient Satisfaction
KW - Schizophrenia/drug therapy
M3 - SCORING: Journal article
VL - 31
SP - 226
EP - 230
JO - J CLIN PSYCHOPHARM
JF - J CLIN PSYCHOPHARM
SN - 0271-0749
IS - 2
M1 - 2
ER -